Market Overview

UPDATE: Morgan Stanley Reiterates on Walgreen Company on 2QFY14 Earnings Preview

Share:
Related WAG
IPO Outlook: API-Focused Software Tech Company Apigee Is A Silent Growth Story
Jana Partners' Barry Rosenstein: 'The Walgreens Situation Is Terrific'

In a report published Wednesday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on Walgreen Company (NYSE: WAG), but removed the $68.00 price target.

In the report, Morgan Stanley noted, “WAG shares up 17% since January and holding on to gains March to-date, heading into what is likely to be soft earnings as investors focus on LT opportunities. Key to share performance will be mgmt commentary regarding synergies, timing of step 2 of AB deal, and strategic direction.”

Walgreen Company closed on Tuesday at $67.20.

Latest Ratings for WAG

DateFirmActionFromTo
Dec 2014BarclaysMaintainsEqual-weight
Dec 2014JP MorganMaintainsOverweight
Dec 2014SunTrust Robinson HumphreyDowngradesBuyNeutral

View More Analyst Ratings for WAG
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Price Target Analyst Ratings

 

Related Articles (WAG)

Around the Web, We're Loving...

Get Benzinga's Newsletters